Back to Trades
Ellis Andrea
DirectorCIK 0001877680
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 4
- Buy transactions
- 0
- Sell transactions
- 3
- Companies
- 1
- Active
- 2025–2026
Across 4 filings between 2025–2026, Ellis Andrea, Director, has disclosed $9.1M in transactions — all concentrated in BridgeBio Pharma, Inc. (BBIO). Their disclosed trades are heavily weighted toward selling — $0 in buys and $6.5M in sells. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
4 loaded
| Jul 13 | BBIO BridgeBio Pharma, Inc. | Ellis Andrea | Director | Sell | $1.4M |
| Jun 24 | BBIO BridgeBio Pharma, Inc. | Ellis Andrea | Director | Grant | $363.7K |
| Mar 6 | BBIO BridgeBio Pharma, Inc. | Ellis Andrea | Director | Sell | $4.2M |
| Aug 7 | BBIO BridgeBio Pharma, Inc. | Ellis Andrea | Insider | Sell | $841.2K |
4 filings